• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CONCORD MANUFACTURING 2008T HEMODIALYSIS SYS., WITH CDX; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CONCORD MANUFACTURING 2008T HEMODIALYSIS SYS., WITH CDX; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Catalog Number 190713
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Loss of consciousness (2418)
Event Date 03/07/2024
Event Type  Injury  
Manufacturer Narrative
Clinical review: it was confirmed the patient¿s loc due to a cardiac arrhythmia, and the associated hospitalization were not due to a deficiency or malfunction of any fresenius product(s) or device(s).Based on the provided information, there is no indication of a serious injury, patient death, or other adverse event related to a fresenius product or other issue.The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity. .
 
Event Description
A user facility biomedical technician (biomed) reported to fresenius that the hemodialysis (hd) patient experienced an adverse event approximately 13 seconds after treatment initiation on the 2008t machine and required medical intervention.The biomed confirmed that the patient did not pass away.Upon follow up with the patient¿s hd registered nurse, it was reported this patient experienced loss of consciousness (loc) at the beginning of an hd treatment in the in-center clinic on (b)(6) 2024.It was explained the patient¿s loc was attributed to a preexisting cardiac arrhythmia that has caused fainting in the past while not on hd therapy.It was believed that the patient would have fainted whether they were on the machine or not and it was determined the patient¿s loc was completely unrelated to the hd treatment.The patient had loc shortly after the needle was placed into their arteriovenous access and before blood ran through the 2008t hd system.The treatment was immediately stopped, and emergency services were activated.It was affirmed that there was no blood loss involved with this event.The patient regained consciousness shortly after and they were transported to the hospital by emergency services.The patient was admitted to the hospital on the same day and diagnosed with an exacerbation of a cardiac arrhythmia.The patient was able to undergo hd therapy on a hospital provided hd device (unknown brand and model) for the duration of the admission.The patient had an uneventful hospital course and was discharged to home on (b)(6) 2024.The patient recovered from this event and continues hd therapy on an in-center basis post-discharge.
 
Event Description
A user facility biomedical technician (biomed) reported to fresenius that the hemodialysis (hd) patient experienced an adverse event approximately 13 seconds after treatment initiation on the 2008t machine and required medical intervention.The biomed confirmed that the patient did not pass away.Upon follow up with the patient¿s hd registered nurse, it was reported this patient experienced loss of consciousness (loc) at the beginning of an hd treatment in the in-center clinic on (b)(6) 2024.It was explained the patient¿s loc was attributed to a preexisting cardiac arrhythmia that has caused fainting in the past while not on hd therapy.It was believed that the patient would have fainted whether they were on the machine or not and it was determined the patient¿s loc was completely unrelated to the hd treatment.The patient had loc shortly after the needle was placed into their arteriovenous access and before blood ran through the 2008t hd system.The treatment was immediately stopped, and emergency services were activated.It was affirmed that there was no blood loss involved with this event.The patient regained consciousness shortly after and they were transported to the hospital by emergency services.The patient was admitted to the hospital on the same day and diagnosed with an exacerbation of a cardiac arrhythmia.The patient was able to undergo hd therapy on a hospital provided hd device (unknown brand and model) for the duration of the admission.The patient had an uneventful hospital course and was discharged to home on (b)(6) 2024.The patient recovered from this event and continues hd therapy on an in-center basis post-discharge.
 
Manufacturer Narrative
Plant investigation: no parts were returned to the manufacturer for physical evaluation.Additionally, no on-site evaluation was performed by a fresenius field service technician (fst).A records review was performed on the reported serial number.An investigation of the device manufacturing records was conducted by the manufacturer.There were no non-conformances, or any associated rework identified during the manufacturing process which could be related to the reported event.In addition, the device history record (dhr) review confirmed the results of the in-progress and final quality control (qc) testing met all requirements.The investigation into the cause of the reported problem was not able to be confirmed.A definitive conclusion regarding the complaint incident cannot be reached without a physical examination of the complaint device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
2008T HEMODIALYSIS SYS., WITH CDX
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
CONCORD MANUFACTURING
director, quality systems
4040 nelson avenue
concord CA 94520
Manufacturer (Section G)
CONCORD MANUFACTURING
director, quality systems
4040 nelson avenue
concord CA 94520
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key18987872
MDR Text Key338726212
Report Number0002937457-2024-00519
Device Sequence Number1
Product Code KDI
UDI-Device Identifier00840861100897
UDI-Public00840861100897
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K150708
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Biomedical Engineer
Type of Report Initial,Followup
Report Date 04/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number190713
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Device AgeMO
Initial Date Manufacturer Received 03/11/2024
Initial Date FDA Received03/27/2024
Supplement Dates Manufacturer Received04/16/2024
Supplement Dates FDA Received04/16/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/21/2013
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age68 YR
Patient SexFemale
Patient Weight121 KG
-
-